Correction to: Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma

Correction to: Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma

Bibliographic Details
Main Authors:	Kai Guo, Yinghua Wei, Ze Wang, Xiaoli Zhang, Xin Zhang, Xinxin Liu, Wenyong Wu, Zhengsheng Wu, Lingqiang Zhang, Chun-Ping Cui
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-06-01
Series:	Cell Death and Disease
Online Access:	https://doi.org/10.1038/s41419-022-04970-y

Similar Items

Deubiquitylase OTUD6B Governs pVHL Stability in an Enzyme‐Independent Manner and Suppresses Hepatocellular Carcinoma Metastasis
by: Xinxin Liu, et al.
Published: (2020-04-01)

DUB-independent regulation of pVHL by OTUD6B suppresses hepatocellular carcinoma
by: Xiaoming Dai, et al.
Published: (2020-04-01)

Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer
by: Hongmiao Dai, et al.
Published: (2024-07-01)

The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis
by: Tongde Du, et al.
Published: (2019-07-01)

Identification of pVHL as a novel substrate for Aurora-A in clear cell renal cell carcinoma (ccRCC).
by: Benedicte Martin, et al.
Published: (2013-01-01)

Deubiquitylase OTUD3 prevents Parkinson’s disease through stabilizing iron regulatory protein 2
by: Fengju Jia, et al.
Published: (2022-04-01)

Author Correction: pVHL-mediated regulation of the anti-angiogenic protein thrombospondin-1 decreases migration of Clear Cell Renal Carcinoma Cell Lines
by: Javier Sevilla-Montero, et al.
Published: (2023-05-01)

Correction: Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)
Published: (2014-01-01)

Correction: Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC).
by: Benedicte Martin, et al.
Published: (2014-01-01)

Identification and Functional Characterization of pVHL-Dependent Cell Surface Proteins in Renal Cell Carcinoma
by: Gunther Boysen, et al.
Published: (2012-06-01)

Inhibition of HIF2α Protein Suppresses pVHL-Driven Tumor Growth.
Published: (2003-12-01)

Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.
by: Keiichi Kondo, et al.
Published: (2003-12-01)

The interaction between the von Hippel-Lindau gene product (pVHL) and hypoxia-inducible factor 1 is disrupted by disease-causing pVHL mutants.
by: Maher, E, et al.
Published: (1999)

Interaction between the von Hippel-Lindau gene product (pVHL) and hypoxia-inducible factor 1 is disrupted by disease causing pVHL mutants
by: Clifford, S, et al.
Published: (1999)

Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1α and hierarchical quality control of pVHL via chaperone system.
by: Jieming Ni, et al.
Published: (2021-01-01)

Effects of point mutations in pVHL on the binding of HIF-1α.
by: Domene, C, et al.
Published: (2012)

Effects of point mutations in pVHL on the binding of HIF-1α
by: Domene, C, et al.
Published: (2012)

Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL.
by: Hon, W, et al.
Published: (2002)

pVHL mediates K63-linked ubiquitination of nCLU.
by: Jing Xue, et al.
Published: (2012-01-01)

MDM2 promotes cancer cell survival through regulating the expression of HIF-1α and pVHL in retinoblastoma
by: Shouhua Zhang, et al.
Published: (2023-01-01)

The pVHL-hIF-1 system. A key mediator of oxygen homeostasis.
by: Maxwell, P, et al.
Published: (2001)

Deubiquitylase OTUD1 confers Erlotinib sensitivity in non-small cell lung cancer through inhibition of nuclear translocation of YAP1
by: Huafeng Liu, et al.
Published: (2022-10-01)

Genetic and Epigenetic Mechanisms Deregulate the CRL2pVHL Complex in Hepatocellular Carcinoma
by: Brenda C. Minatel, et al.
Published: (2022-05-01)

The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer
by: Giovanni Minervini, et al.
Published: (2020-07-01)

Deubiquitylase OTUD3 Mediates Endoplasmic Reticulum Stress through Regulating Fortilin Stability to Restrain Dopaminergic Neurons Apoptosis
by: Ling Chen, et al.
Published: (2023-03-01)

Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01)

VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
by: Athina Ganner, et al.
Published: (2021-07-01)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
by: Junhui Hu, et al.
Published: (2023-04-01)

Up-regulation of pVHL along with down-regulation of HIF-1α by NDRG2 expression attenuates proliferation and invasion in renal cancer cells.
by: Lei Gao, et al.
Published: (2013-01-01)

OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3
by: Boxiang Zhang, et al.
Published: (2020-11-01)

Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer
by: Yonghui Zhang, et al.
Published: (2023-06-01)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
by: Xuechun Wang, et al.
Published: (2022-01-01)

Microtubular stability affects pVHL-mediated regulation of HIF-1alpha via the p38/MAPK pathway in hypoxic cardiomyocytes.
by: Miao Teng, et al.
Published: (2012-01-01)

Deubiquitylation of deubiquitylases
by: Saba Haq, et al.
Published: (2017-01-01)

Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer
by: Meng-Chuan Chen, et al.
Published: (2017-07-01)

Retraction. Up-regulation of pVHL along with down-regulation of HIF-1α by NDRG2 expression attenuates proliferation and invasion in renal cancer cells.
Published: (2014-01-01)

MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma
by: Shuai Tong, et al.
Published: (2017-07-01)

Chemical basis for the selectivity of the von Hippel Lindau tumor suppressor pVHL for prolyl-hydroxylated HIF-1alpha.
by: Illingworth, C, et al.
Published: (2010)

VHL deficiency drives enhancer activation of oncogenes in clear cell renal cell carcinoma
by: Yao, X, et al.
Published: (2017)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
by: Jin Zhang, et al.
Published: (2020-12-01)